Our finding that removal of p21 delays the development of kyphosis in CypB‐deficient mice raises the notion that p21 inhibitors might aid in the treatment of OI, although clearly its role in tumor suppression must not be ignored. The gene discussed is CDKN1A; the disease is osteogenesis imperfecta.